Type I Interferon Increases Inflammasomes Associated Pyroptosis in the Salivary Glands of Patients with Primary Sjögren's Syndrome

키워드

참고문헌 (34)

1. Li H, "Interferons in Sjögren's syndrome : genes, mechanisms, and effects", Front Immunol, 4, pp.290~ (2013)
2. Crow MK, "Type I interferons in autoimmune disease", Annu Rev Pathol, 14, pp.369~393 (2019)
3. Furumoto Y, "Tofacitinib ameliorates murine lupus and its associated vascular dysfunction", Arthritis Rheumatol, 69, pp.148~160 (2017)
4. Lee J, "JAK-1 inhibition suppresses interferon-induced BAFF production in human salivary gland : potential therapeutic strategy for primary Sjögren's syndrome", Arthritis Rheumatol, 70, pp.2057~2066 (2018)
5. Fragoulis GE, "New players in the field of immune-mediated diseases, beyond rheumatoid arthritis", Rheumatology(Oxford), 58, pp.i43~i54 (2019)
6. Kolb JP, "Programmed cell death and inflammation : winter is coming", Trends Immunol, 38, pp.705~718 (2017)
7. Deuteraiou K, "Novel insights into the role of inflammasomes in autoimmune and metabolic rheumatic diseases", Rheumatol Int, 38, pp.1345~1354 (2018)
8. Baldini C, "The P2X7 receptor-inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndrome", J Intern Med, 274, pp.480~489 (2013)
9. Niu L, "Upregulation of nlrp3 inflammasome in the tears and ocular surface of dry eye patients", PLoS One, 10, pp.e0126277~ (2015)
10. Baldini C, "The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin's lymphoma in Sjogren's syndrome : a prospective, observational, single-centre study", J Intern Med, 282, pp.175~186 (2017)
11. Vakrakou AG, "Systemic activation of NLRP3 inflammasome in patients with severe primary Sjögren's syndrome fueled by inflammagenic DNA accumulations", J Autoimmun, 91, pp.23~33 (2018)
12. Vakrakou AG, "Cell-autonomous epithelial activation of AIM2(absent in melanoma-2)inflammasome by cytoplasmic DNA accumulations in primary Sjögren's syndrome", J Autoimmun, 108, pp.102381~ (2020)
13. Liu J, "Enhanced inflammasome activity in systemic lupus erythematosus is mediated via type i interferon-induced up-regulation of interferon regulatory factor 1", Arthritis Rheumatol, 69, pp.1840~1849 (2017)
14. Kopitar-Jerala N, "The role of interferons in inflammation and inflammasome activation", Front Immunol, 8, pp.873~ (2017)
15. Man SM, "The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by Francisella infection", Nat Immunol, 16, pp.467~475 (2015)
16. Guarda G, "Type I interferon inhibits interleukin-1 production and inflammasome activation", Immunity, 34, pp.213~223 (2011)
17. Vitali C, "Classification criteria for Sjögren’s syndrome : a revised version of the European criteria proposed by the American-European Consensus Group", Ann Rheum Dis, 61, pp.554~558 (2002)
18. Shiboski SC, "American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort", Arthritis Care Res(Hoboken), 64, pp.475~487 (2012)
19. D’Cunha J, "In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine", J Immunol, 157, pp.4100~4108 (1996)
20. Lin LC, "Cross-contamination of the human salivary gland HSG cell line with HeLa cells : a STR analysis study", Oral Dis, 24, pp.1477~1483 (2018)
21. Liu T, "TRIM11 suppresses AIM2 inflammasome by degrading AIM2 via p62-dependent selective autophagy", Cell Reports, 16, pp.1988~2002 (2016)
22. Yang F, "MicroRNA-223 acts as an important regulator to Kupffer cells activation at the early stage of Con A-induced acute liver failure via AIM2 signaling pathway", Cell Physiol Biochem, 34, pp.2137~2152 (2014)
23. Chen L, "MicroRNA-223 promotes type I interferon production in antiviral innate immunity by targeting forkhead box protein O3(FOXO3)", J Biol Chem, 291, pp.14706~14716 (2016)
24. Gurung P, "Novel roles for caspase-8 in IL-1β and inflammasome regulation", Am J Pathol, 185, pp.17~25 (2015)
25. Yu J, "Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells", Cell Death Dis, 10, pp.193~ (2019)
26. Sarhan J, "Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection", Proc Natl Acad Sci U S A, 115, pp.E10888~ (2018)
27. Taabazuing CY, "Pyroptosis and apoptosis pathways engage in bidirectional crosstalk in monocytes and macrophages", Cell Chem Biol, 24, pp.507~514 (2017)
28. Li Y, "Type I IFN operates pyroptosis and necroptosis during multidrug-resistant A. baumannii infection", Cell Death Differ, 25, pp.1304~1318 (2018)
29. Kayagaki N, "IRF2 transcriptionally induces GSDMD expression for pyroptosis", Sci Signal, 12, pp.eaax4917~ (2019)
30. Duan X, "Differential roles for the interferon-inducible IFI16 and AIM2 innate immune sensors for cytosolic DNA in cellular senescence of human fibroblasts", Mol Cancer Res, 9, pp.589~602 (2011)
31. Man SM, "Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases", Immunol Rev, 277, pp.61~75 (2017)
32. Ma Y, "Research progress of the relationship between pyroptosis and disease", Am J Transl Res, 10, pp.2213~2219 (2018)
33. Li Y, "The DNA repair nuclease MRE11A functions as a mitochondrial protector and prevents T cell pyroptosis and tissue inflammation", Cell Metab, 30, pp.477~492 (2019)
34. Faliti CE, "P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus", J Exp Med, 216, pp.317~336 (2019)

관련 논문AI추천